相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
John A. Bartlett et al.
AIDS (2012)
Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis
Raph L. Hamers et al.
AIDS (2012)
Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis
Olawale Ajose et al.
AIDS (2012)
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure
Jonathan Z. Li et al.
AIDS (2012)
Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa
Kim C. E. Sigaloff et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy
Carole L. Wallis et al.
ANTIVIRAL THERAPY (2012)
Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients
Roos E. Barth et al.
ANTIVIRAL THERAPY (2012)
HIV-1 Drug Resistance Resulting from Antiretroviral Therapy Far Exceeds That From Pre-exposure Prophylaxis
Urvi M. Parikh et al.
CLINICAL INFECTIOUS DISEASES (2012)
HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries
Diane E. Bennett et al.
CLINICAL INFECTIOUS DISEASES (2012)
Surveillance of Transmitted Drug-Resistant HIV Among Young Pregnant Women in Ouagadougou, Burkina Faso
Antoine Somda et al.
CLINICAL INFECTIOUS DISEASES (2012)
Maternal HIV-1 Disease Progression 18-24 Months Postdelivery According to Antiretroviral Prophylaxis Regimen (Triple-Antiretroviral Prophylaxis During Pregnancy and Breastfeeding vs Zidovudine/Single-Dose Nevirapine Prophylaxis): The Kesho Bora Randomized Controlled Trial
Paulin Fao et al.
CLINICAL INFECTIOUS DISEASES (2012)
Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies
Raph L. Hamers et al.
CLINICAL INFECTIOUS DISEASES (2012)
Surveillance of Transmitted HIV-1 Drug Resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009
G. M. Hunt et al.
CLINICAL INFECTIOUS DISEASES (2012)
Prediction of Treatment Failure Using 2010 World Health Organization Guidelines Is Associated With High Misclassification Rates and Drug Resistance Among HIV-Infected Cambodian Children
Benjamin P. Westley et al.
CLINICAL INFECTIOUS DISEASES (2012)
Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007-2010
Neil Parkin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network
Neil Parkin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men
D. Dolling et al.
HIV MEDICINE (2012)
Effects of Short-Course Zidovudine on the Selection of Nevirapine-Resistant HIV-1 in Women Taking Single-Dose Nevirapine
Mark A. Micek et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa
Kim C. E. Sigaloff et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
Ravindra K. Gupta et al.
LANCET (2012)
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study
Raph L. Hamers et al.
LANCET INFECTIOUS DISEASES (2012)
Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection
Karin Nielsen-Saines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children
Avy Violari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
Michael C. Thigpen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
J. M. Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Preexposure Prophylaxis for HIV Infection among African Women
Lut Van Damme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings
Karen Schneider et al.
AIDS (2011)
Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings
Andrew N. Phillips et al.
AIDS (2011)
Global trends in molecular epidemiology of HIV-1 during 2000-2007
Joris Hemelaar et al.
AIDS (2011)
Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala
Nicaise Ndembi et al.
AIDS (2011)
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients
Avelin F. Aghokeng et al.
AIDS (2011)
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine
Gillian M. Hunt et al.
AIDS (2011)
Rapid Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Children Less Than Two Years of Age Initiating Protease Inhibitor-Based Therapy in South Africa
Barbara S. Taylor et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa
Kim C. E. Sigaloff et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure A Systematic Review and Pooled Analysis
Jonathan Z. Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Use of Dried-Blood-Spot Samples and In-House Assays To Identify Antiretroviral Drug Resistance in HIV-Infected Children in Resource-Constrained Settings
Carrie Ziemniak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Antiretroviral Resistance Patterns and Factors Associated With Resistance in Adult Patients Failing NNRTI-Based Regimens in the Western Cape, South Africa
Gert U. van Zyl et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review
Kim C. E. Sigaloff et al.
LANCET INFECTIOUS DISEASES (2011)
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial
Nicolas Meda et al.
LANCET INFECTIOUS DISEASES (2011)
Time to get serious about HIV anti retroviral resistance
Evan Wood et al.
LANCET INFECTIOUS DISEASES (2011)
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study
Raph L. Hamers et al.
LANCET INFECTIOUS DISEASES (2011)
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study
Linda Wittkop et al.
LANCET INFECTIOUS DISEASES (2011)
MECHANISMS OF DISEASE Development of Antiretroviral Drug Resistance
Mark A. Wainberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP)
Ume L. Abbas et al.
PLOS ONE (2011)
Long-term Outcome of Children Receiving Antiretroviral Treatment in Rural South Africa Substantial Virologic Failure on First-line Treatment
Roos E. Barth et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Lopinavir/Ritonavir-based Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-infected Naive Children Rare Protease Inhibitor Resistance Mutations But High Lamivudine/Emtricitabine Resistance at the Time of Virologic Failure
Pierre Frange et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon
Joseph Fokam et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data
Sydney Rosen et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2011)
Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance
Virginie Supervie et al.
SCIENTIFIC REPORTS (2011)
Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa
Carole L. Wallis et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Cote d'Ivoire
Armelle Pasquet et al.
PLOS ONE (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy
Mina C. Hosseinipour et al.
AIDS (2009)
Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1
Dimitrios Coutsinos et al.
JOURNAL OF VIROLOGY (2009)
PROTEASE INHIBITOR RESISTANCE IN SOUTH AFRICAN CHILDREN WITH VIROLOGIC FAILURE
Gert U. van Zyl et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy
Andrew Boulle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa
Catherine G. Sutcliffe et al.
LANCET INFECTIOUS DISEASES (2008)
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy
G Jourdain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
SH Eshleman et al.
AIDS (2001)
分享论文
